GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Corline Biomedical CLBIO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

12.80

-1.16%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 7.7m

FY2016FY2025

Net income

−SEK 14.7m

FY2016FY2025

Free cash flow

−SEK 17.7m

FY2016FY2025

Shareholders' equity

SEK 93.8m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 7.7mSEK 9.8mSEK 25.0mSEK 23.6mSEK 7.1mSEK 3.7mSEK 1.1mSEK 1.6mSEK 638,000SEK 947,000
Operating income−SEK 14.2m−SEK 23.2m−SEK 1.8mSEK 2.3m−SEK 6.9m−SEK 7.3m−SEK 9.5m−SEK 6.8m−SEK 7.8m−SEK 5.2m
Net income−SEK 14.7m−SEK 23.2m−SEK 1.8mSEK 2.3m−SEK 6.9m−SEK 7.3m−SEK 9.5m−SEK 6.8m−SEK 7.8m−SEK 5.2m
Diluted earnings per share-0.58-1.02-0.080.11-0.34-0.42-0.56-0.42-0.59-0.40

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 98.6mSEK 94.8mSEK 100.1mSEK 101.8mSEK 101.7mSEK 58.3mSEK 63.8mSEK 62.9mSEK 51.4mSEK 41.3m
Cash and short-term investmentsSEK 20.6mSEK 17.7mSEK 17.0mSEK 26.2mSEK 41.6mSEK 9.0mSEK 22.9mSEK 27.6mSEK 16.9mSEK 11.9m
Total liabilitiesSEK 4.8mSEK 7.8mSEK 6.8mSEK 7.2mSEK 9.4mSEK 6.3mSEK 4.4mSEK 8.0mSEK 5.5mSEK 2.5m
Shareholders' equitySEK 93.8mSEK 86.9mSEK 93.3mSEK 94.6mSEK 92.2mSEK 52.0mSEK 59.3mSEK 55.0mSEK 45.9mSEK 38.7m
Shares outstanding25m23m21m21m20m17m17m16m13m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 17.7m−SEK 8.6mSEK 886,000−SEK 6.5m−SEK 4.8m−SEK 5.1m−SEK 13.8m−SEK 4.1m−SEK 5.0m−SEK 7.2m
Capital spending−SEK 47,000−SEK 7.5m−SEK 10.6m−SEK 9.0m−SEK 9.6m−SEK 8.8m−SEK 4.8m−SEK 937,000−SEK 5.0m−SEK 8.5m
Free cash flow−SEK 17.7m−SEK 16.1m−SEK 9.7m−SEK 15.5m−SEK 14.5m−SEK 13.9m−SEK 18.7m−SEK 5.0m−SEK 10.0m−SEK 15.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 4.7mSEK 4.3mSEK 2.1mSEK 1.3mSEK 2.2mSEK 2.1mSEK 2.0mSEK 1.8m
Operating income−SEK 1.4m−SEK 2.5m−SEK 5.1m−SEK 3.4m−SEK 3.3m−SEK 3.1m−SEK 14.1m−SEK 3.0m
Net income−SEK 1.4m−SEK 2.5m−SEK 5.0m−SEK 3.4m−SEK 3.3m−SEK 3.1m−SEK 14.2m−SEK 3.0m
Diluted earnings per share-0.05-0.10-0.20-0.13-0.13-0.12-0.62-0.13
Cash from operations—−SEK 5.0m−SEK 6.0m−SEK 2.0m−SEK 2.0m−SEK 5.0m−SEK 5.0m−SEK 4.0m
Total assetsSEK 114.2mSEK 116.0mSEK 98.6mSEK 82.3mSEK 86.3mSEK 89.6mSEK 94.8mSEK 93.0m
Cash and short-term investmentsSEK 33.0mSEK 32.9mSEK 20.6mSEK 5.8mSEK 8.3mSEK 11.7mSEK 17.7mSEK 7.3m
Shareholders' equitySEK 99.0mSEK 100.4mSEK 93.8mSEK 77.2mSEK 80.6mSEK 83.8mSEK 86.9mSEK 84.5m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-31.3%15.7%22.1%
Operating income—14.3%9.6%
Net income—15.1%9.7%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-214.4%-55.8%-66.5%-104.9%
Net margin-217.5%-56.6%-67.2%-105.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-28.4-8.6-177.085.1-43.1-34.2-26.2-42.4-20.3-24.5
Price to sales54.620.512.88.442.367.5235.1184.1248.6135.9

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.